Constitutive binding of the transcription factor interleukin-2 (IL-2) enhancer binding factor to the IL-2 promoter

被引:34
|
作者
Nirula, A
Moore, DJ
Gaynor, RB
机构
[1] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DIV MOL VIROL,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DIV HEMATOL ONCOL,DALLAS,TX 75235
[3] UNIV TEXAS,SW MED CTR,DEPT MICROBIOL,DALLAS,TX 75235
关键词
D O I
10.1074/jbc.272.12.7736
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A positive regulatory element in the interleukin-2 (IL-2) promoter, designated the antigen receptor response element-2, is essential for the induction of IL-2 gene expression upon the binding of an inducible multiprotein complex of proteins known as nuclear factor of activated T cells, In the current study, we demonstrated that the winged helix transcription factor IL-2 enhancer binding factor (ILF) is constitutively expressed in both resting and activated Jurkat cells and binds to two adjacent sequence motifs immediately downstream of the binding site for NFAT. One of these elements has a high degree of homology with consensus binding sites for a variety of winged-helix DNA binding proteins, and the second site functions to modulate ILF binding, Mutagenesis of each of the two sequence elements required for ILF binding decreased IL-2 promoter activity when assayed in transfection assays, Although ILF bound constitutively to the IL-2 promoter, it was not detected as a component of the NFAT complex, These results suggest that important regulatory sequences in the IL-2 promoter are bound by ILF and that this binding may be involved in the control of IL-2 gene expression.
引用
收藏
页码:7736 / 7745
页数:10
相关论文
共 50 条
  • [41] ROLE OF INTERLEUKIN-2 (IL-2) IN CANCER-RELATED IMMUNE-DEFICIENCY - INVITRO RESPONSE TO IL-2, PRODUCTION OF IL-2, AND IL-2 RECEPTOR EXPRESSION IN PATIENTS WITH ADVANCED CANCER
    MANTOVANI, G
    COIANA, A
    MASSIDDA, A
    PROTO, E
    FLORIS, C
    MACCIO, A
    PUSCEDDU, G
    DELGIACCO, GS
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 149 - 159
  • [42] Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity
    Jan, TR
    Rao, GK
    Kaminski, NE
    MOLECULAR PHARMACOLOGY, 2002, 61 (02) : 446 - 454
  • [43] THE INTERLEUKIN-2 RECEPTOR (IL-2R) - THE IL-2R ALPHA SUBUNIT ALTERS THE FUNCTION OF THE IL-2R BETA SUBUNIT TO ENHANCE IL-2 BINDING AND SIGNALING BY MECHANISMS THAT DO NOT REQUIRE BINDING OF IL-2 TO IL-2R ALPHA SUBUNIT
    GRANT, AJ
    ROESSLER, E
    JU, G
    TSUDO, M
    SUGAMURA, K
    WALDMANN, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) : 2165 - 2169
  • [44] CLONING OF THE BOVINE INTERLEUKIN-2 (IL-2) RECEPTOR CDNA
    WEINBERG, A
    ELLIOTT, J
    PAETKAU, V
    BLEACKLEY, C
    MAGNUSON, N
    REEVES, R
    MAGNUSON, J
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 770 - 770
  • [45] INTERLEUKIN-2 (IL-2) INDUCES PHOSPHORYLATION OF PLATELET PROTEINS
    AIKEN, ML
    FASEB JOURNAL, 1994, 8 (04): : A337 - A337
  • [46] IMMUNE RECONSTITUTION IN PRIMARY IMMUNODEFICIENCIES BY INTERLEUKIN-2 (IL-2)
    MAZUMDER, A
    GUERRA, IC
    ROSENBLATT, HM
    SHEARER, WT
    PEDIATRIC RESEARCH, 1985, 19 (04) : A278 - A278
  • [47] INTERLEUKIN-2 (IL-2) PRODUCTION IN UREMIC AND DIALYSIS PATIENTS
    CHOI, KH
    KIM, YK
    HA, SK
    LEE, HY
    HAN, DS
    KIDNEY INTERNATIONAL, 1991, 39 (01) : 216 - 216
  • [48] CARDIOTOXICITY OF HUMAN RECOMBINANT INTERLEUKIN-2 (IL-2) IN RATS
    ZHANG, J
    HERMAN, EH
    MCCLURE, HM
    CHADWICK, DP
    FERRANS, VJ
    FASEB JOURNAL, 1991, 5 (04): : A507 - A507
  • [49] INTERLEUKIN-2 (IL-2) ABNORMALITIES IN RHEUMATOID-ARTHRITIS
    ANDARY, M
    COMBE, B
    KLEIN, B
    SANY, J
    CLOT, J
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 323 - 323
  • [50] INVITRO NORMALIZATION OF UREMIC LYMPHOCYTES BY INTERLEUKIN-2 (IL-2)
    LANGHOFF, E
    LADEFOGED, J
    OLGAARD, K
    MADSEN, S
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 273 - 273